Neuroprotective effect and mechanism of baicalin on Parkinson’s disease model induced by 6-OHDA

References

• Riedel O, Bitters D, Amann U, Garbe E, Langner I. Estimating the prevalence of Parkinson’s disease (PD) and proportions of patients with associated dementia and depression among the older adults based on secondary claims data. Int J Geriatr Psychiatry. 2016;31(8):938–943.26764603
   PubMed Web of Science ®Google Scholar
• Aarsland D. Cognitive impairment in Parkinson’s disease and dementia with Lewy bodies. Parkinsonism Relat Disord. 2016;22(Suppl 1):S144–S148.26411499
   PubMed Web of Science ®Google Scholar
• Sarkar S, Raymick J, Imam S. Neuroprotective and therapeutic strategies against Parkinson’s disease: recent perspectives. Int J Mol Sci. 2016;17(6):904.
   PubMed Web of Science ®Google Scholar
• Hindle JV, Hurt CS, Burn DJ, et al. The effects of cognitive reserve and lifestyle on cognition and dementia in Parkinson’s disease – a longitudinal cohort study. Int J Geriatr Psychiatry. 2016;31(1):13–23.25781584
   PubMed Web of Science ®Google Scholar
• Chen Y, Lian Y, Ma Y, et al. The expression and significance of tyrosine hydroxylase in the brain tissue of Parkinson’s disease rats. Exp Ther Med. 2017;14(5):4813–4816.29201184
   PubMed Web of Science ®Google Scholar
• Zhang X, Li Y, Liu C. Alteration of enteric monoamines with monoamine receptors and colonic dysmotility in 6-hydroxydopamine-induced Parkinson's disease rats. Transl Res. 2015;166(2):152-162.
   Google Scholar
• Lindenbach D, Palumbo N, Ostock C. Side-effect profile of serotoninergic treatments for Parkinson’s disease and L-DOPA-induced dyskinesia in rats. Br J Pharmacol 2014;172(1):119-130.
   Google Scholar
• Kucinski A, Albin RL, Lustig C, Sarter M. Modeling falls in Parkinson’s disease: slow gait, freezing episodes and falls in rats with extensive striatal dopamine loss. Behav Brain Res. 2015;282:155–164.25595423
   PubMed Web of Science ®Google Scholar
• Xiong P, Chen X, Guo C, Zhang N, Ma B. Baicalin and deferoxamine alleviate iron accumulation in different brain regions of Parkinson’s disease rats. Neural Regen Res. 2012;7(27):2092–2098.25558221
   PubMed Web of Science ®Google Scholar
• Chen X, Zhang N, Zou HY. Protective effect of baicalin on mouse with Parkinson’s disease induced by MPTP. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2007;27(11):1010–1012.18173149
   PubMedGoogle Scholar
• Guo C, Chen X, Xiong P. Baicalin suppresses iron accumulation after substantia nigra injury: relationship between iron concentration and transferrin expression. Neural Regen Res. 2014;9(6):630.25206866
   PubMed Web of Science ®Google Scholar
• Dong G, Wei D, Wang J, et al. Study of the cardiotoxicity of Venenum Bufonis in rats using an 1H NMR-based metabolomics approach. PLoS One. 2015;10(3):e0119515.25781638
   PubMed Web of Science ®Google Scholar
• Deng M, Zhang M, Sun F, et al. A gas chromatography-mass spectrometry based study on urine metabolomics in rats chronically poisoned with hydrogen sulfide. Biomed Res Int. 2015;2015:295241–295246.25954748
   PubMed Web of Science ®Google Scholar
• Long Y, Dong X, Yuan Y, et al. Metabolomics changes in a rat model of obstructive jaundice: mapping to metabolism of amino acids, carbohydrates and lipids as well as oxidative stress. J Clin Biochem Nutr. 2015;57(1):50–59.26236101
   PubMed Web of Science ®Google Scholar
• Xu J, Jiang H, Li J, et al. 1H NMR-based metabolomics investigation of copper-laden rat: a model of Wilson’s disease. PLoS One. 2015;10(4):e0119654.25849323
   PubMed Web of Science ®Google Scholar
• Zhao H, Si Z-H, Li M-H, et al. Pyrazinamide-induced hepatotoxicity and gender differences in rats as revealed by a 1H NMR based metabolomics approach. Toxicol Res. 2017;6(1):17–29.
   PubMed Web of Science ®Google Scholar
• Kim KS, Bang E. Metabolomics profiling of the effects of taurine supplementation on dyslipidemia in a high-fat-diet-induced rat model by 1H NMR spectroscopy. Adv Exp Med Biol. 2017;975:329–336.28849467
   PubMed Web of Science ®Google Scholar
• Zheng X, Chen X, Guo M, et al. Changes in salsolinol production and salsolinol synthase activity in Parkinson’s disease model. Neurosci Lett. 2018;673:39–43.29454627
   PubMed Web of Science ®Google Scholar
• Zhang W, Zhang L, Liu L, Wang X. Time course study of fractional anisotropy in the substantia nigra of a parkinsonian rat model induced by 6-OHDA. Behav Brain Res. 2017;328:130–137.28390876
   PubMed Web of Science ®Google Scholar
• Antipova VA, Holzmann C, Schmitt O, Wree A, Hawlitschka A. Botulinum neurotoxin a injected ipsilaterally or contralaterally into the striatum in the rat 6-OHDA model of unilateral Parkinson’s disease differently affects behavior. Front Behav Neurosci. 2017;11:119.28680396
   PubMed Web of Science ®Google Scholar
• Hansen HH, Fabricius K, Barkholt P, et al. Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson’s disease. Brain Res. 2016;1646:354–365.27233809
   PubMed Web of Science ®Google Scholar
• Ru X, Yi S, Rui H, et al. Neuroprotective effects of SCM198 on 6-hydroxydopamine-induced behavioral deficit in rats and cytotoxicity in neuronal SH-SY5Y cells. Neurochem Int. 2011; 58(8): 851-860.
   Google Scholar
• Yang J, Song S, Li J, Liang T. Neuroprotective effect of curcumin on hippocampal injury in 6-OHDA-induced Parkinson’s disease rat. Pathol Res Pract. 2014;210(6):357–362.24642369
   PubMed Web of Science ®Google Scholar
• Xie L, Xin Tiong C, Bian J. Therapeutic effect of ACS84 on Parkinson’s disease in 6-OHDA-induced rat model. PLoS One 2013; 8(4): e60200.
   Google Scholar
• Sánchez-Iglesias S, Méndez-Alvarez E, Iglesias-González J, et al. Brain oxidative stress and selective behaviour of aluminium in specific areas of rat brain: potential effects in a 6-OHDA-induced model of Parkinson’s disease. J Neurochem. 2009;109(3):879–888.19425176
   PubMed Web of Science ®Google Scholar
• Ozsoy O, Yildirim FB, Ogut E, et al. Melatonin is protective against 6-hydroxydopamine-induced oxidative stress in a hemiparkinsonian rat model. Free Radic Res. 2015;49(8):1004–1014.25791066
   PubMed Web of Science ®Google Scholar
• Noor NA, Mohammed HS, Mourad IM, Khadrawy YA, Aboul Ezz HS. A promising therapeutic potential of cerebrolysin in 6-OHDA rat model of Parkinson’s disease. Life Sci. 2016;155:174–179.27210889
   PubMed Web of Science ®Google Scholar
• Zhao C, Li H, Zhao X-J, et al. Heat shock protein 60 affects behavioral improvement in a rat model of Parkinson’s disease grafted with human umbilical cord mesenchymal stem cell-derived dopaminergic-like neurons. Neurochem Res. 2016;41(6):1238–1249.26758268
   PubMed Web of Science ®Google Scholar
• Pang Y, Lin S, Wright C, et al. Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats. Neuroscience. 2016;318:157–165.26777890
   PubMed Web of Science ®Google Scholar
• Chen L, Zhang L, Wang X, Lin H, du L. Determination of dopamine and its relativity of baicalin in rat nuclei after intravenous administration of flavonoids from Scutellariae radix. Biomed Chromatogr. 2007;21(1):84–88.17080509
   PubMed Web of Science ®Google Scholar
• Zhu W, Ma S, Qu R, Kang D, Liu Y. Antidepressant effect of baicalin extracted from the root of Scutellaria baicalensis in mice and rats. Pharm Biol. 2006;44(7):503–510.
   Web of Science ®Google Scholar
• Wang WW, Jc H, Ding HJ. Effect of tianma gouteng drink on the behavioural and oxidation stress response of Parkinson’s disease rat. Zhongguo Laonian Xue Zazhi 2010;30: 1657-1659.
   Google Scholar
• Coune P, Craveiro M, Gaugler M, et al. An in vivo ultrahigh field 14.1 T 1 H-MRS study on 6-OHDA and α-synuclein-based rat models of Parkinson’s disease: GABA as an early disease marker. NMR Biomed. 2013;26(1):43–50.22711560
   PubMed Web of Science ®Google Scholar
• Meng T, Yuan S, Zheng Z, Liu T, Lin L. Effects of endogenous melatonin on glutamate and GABA rhythms in the striatum of unilateral 6-hydroxydopamine-lesioned rats. Neuroscience. 2015;286:308–315.25499317
   PubMed Web of Science ®Google Scholar
• El Arfani A, Albertini G, Bentea E, et al. Alterations in the motor cortical and striatal glutamatergic system and D-serine levels in the bilateral 6-hydroxydopamine rat model for Parkinson’s disease. Neurochem Int. 2015;88:88–96.26172319
   PubMed Web of Science ®Google Scholar